Michael Lu, Ph.D., is an associate professor of biomedical science. 1972: Intern, Infectious Disease, Veterinary Hospital, National Taiwan University, Taipei, Taiwan 1981: Resident, Veterinary Hospital, National Taiwan University, Taipei, Taiwan 1982: B.V.M., National Taiwan University, R.O.C. 1988: Ph.D., Molecular and Cellular Biology, University of Massachusetts, Amherst. 2006- Present: Associate Professor, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida 1992-2006: Director, Urologic Oncology Research, Brigham and Women's Hospital 1994-2006: Assistant Professor, Department of Surgery, Harvard Medical School 1992-1994: Instructor, Department of Surgery, Harvard Medical School 1989-1990: Research Fellow, Neuromuscular Disease, Muscular Dystrophy Association 1988-1990: Postdoctoral Research Fellow, Pathology, Dana Farber Cancer Institute and Harvard Medical School
Regine Schneider-Stock (Photo source ) is a professor at the University of Erlangen ( Friedrich-Alexander University Erlangen-Nuremberg , Friedrich Alexander-University Erlangen-Nuremberg), not a doctor. His specialty was pathology (experimental cancer pathology: damage to cells and DNA by oxidative stress).
Xueyuan Cao completed his PhD training in Molecular, Cellular, and Developmental Biology (MCDB) from Iowa State University in 2005 and got a MS degree in Statistics from Iowa State University in 2006. He also obtained a PhD in Applied Statistics from University of Memphis in 2014. Xueyuan joined St. Jude Children’s Research Hospital in 2007 and worked as Lead Senior Biostatistician supporting the Leukemia and Lymphoma Research Group. In addition to retrospective and prospective studies in clinical trials, he conducted research in genome-wide association analysis (GWAs) and integrating multiple forms of genomic data and clinical outcomes. Dr. Cao joined UT Health Science Center as Assistant Professor for Nursing Research Programs in the College of Nursing in October 2017. Dr. Cao provides statistical support in designing, analyzing, and reporting studies/trials across the College of Nursing and conducts his own methodological research on analyzing high dimension genomic data in cohort studies. He also serves as course co-director of Biostats for Health Sci and help CON PhD students. Dr. Cao is a member of American Statistical Association (ASA), International Chinese Statistical Association (ICSA) and serve as treasurer of West Tennessee Chapter of American Statistical Association. He also serves as a member of editorial boards for 3 biology or biostatistics journals. He has authored or co-authored over 40 scientific papers and published 3 software packages in Bioconductor.
Dr. Boothman grew up in Detroit, Michigan, and earned his B.S. at the University of Michigan-Ann Arbor. He did his graduate work in microbiology and immunology at the University of Miami Medical School, where he received his Ph.D. under the mentorship of Dr. Sheldon Greer. His research focused on the biochemistry and pharmacology of anticancer drugs, specifically 5-fluoro-deoxycytidine derivatives. He did postdoctoral research at the Dana-Farber Cancer Institute of Harvard Medical School with Dr. Arthur B. Pardee. There, he investigated changes in several aspects of cancer cells before and after cell stress: cell cycle checkpoint regulation, molecular biology, and gene expression. His studies on β-lapachone as a radiosensitizer and DNA repair inhibitor began at this time. Dr. Boothman also discovered and cloned the first proteins and transcripts induced by ionizing radiation (IR). In 1990, Dr. Boothman became Assistant Professor at the University of Michigan-Ann Arbor and continued his investigations of x-ray-inducible proteins (Boothman et al., Cancer Research, 1988), and x-ray-inducible transcripts leading to proteins (Boothman et al., PNAS, 2000). He discovered xip8 (clusterin) and its induction by super-low levels of IR exposure. Dr. Boothman then joined the faculty in the Department of Human Oncology at the University of Wisconsin-Madison, where he rose to Associate Professor with tenure and became the Vice Chairman of Radiation Oncology, and Division Head of Molecular Radiation Oncology. In 1998, Dr. Boothman accepted an Endowed Professorship at Case Western Reserve University and became heavily involved in the Cancer Center. In 2000, he became the Associate Director for Basic Science and headed the research effort in the Cancer Center’s Wolstein Research Building. In 2005, Dr. Boothman and his close colleague Dr. Jinming Gao moved to the University of Texas Southwestern Medical Center to start the Cell Stress and Cancer Nanomedicine Program. In 2017, Dr. Boothman moved to the Indiana University School of Medicine where he accepted the position of Professor of Biochemistry and Molecular Biology, and became the Sid and Lois Eskenazi Chair in Cancer Research, and the Associate Director of Translational Researchin the Simon Cancer Center. Dr. Boothman has trained 16 Ph.D. students, two M.D./Ph.D. students, and more than 40 postdoctoral fellows and residents, who enjoy positions around the nation and in seven different countries and in various aspects of scientific research.
Dr. Mauro luisetto university curriculum studiorum in Turin university and Pavia university Pharm.d., applied pharmacology university specialization, advanced university course clinical pharmacist. European specialist in laboratory medicine , EC4 registered, public hospital pharmacist manager 8 EQF LEVEL Several course in management field( project, strategic, change management, total quality m., knowledge manag. , Healthcare mang.Human resource manag.) Author of many publications in field of: pharmaceutical care, clnical pharmacy, pathology Infectious disease , surgery , neuroscience, management , economics. Execution contract DIRECTOR med gas public hospital Italy Antidothes stokes responsible for provincial hospital Editor in chief or editorial board member in many scientific journal Global clinical pharmacy academy member since 2013 Officially invited in many international scientific congress.
Aadel Chaudhuri, MD, PhD, is an assistant professor in radiation oncology and a physician-scientist who treats lung cancer. Dr. Chaudhuri completed his medical degree at Stanford, PhD at Caltech, and undergraduate degrees at MIT. He completed his residency in radiation oncology at the Stanford Cancer Institute, where he did postdoctoral work under the Holman Pathway with Dr. Maximilian Diehn and Dr. Ash Alizadeh, showing that circulating tumor DNA (ctDNA) can serve as a biomarker for molecular residual disease (MRD) after curative-intent lung cancer treatment. He joined the faculty at Washington University in 2018, where he is continuing this line of research.
Dr. Teng is an Assistant Professor at Augusta University and a member of Georgia Cancer Center. He has authored more than 80 articles and chapters in peer-reviewed journals and books. He is an editor for many reputed journals (e.g. Journal of Experimental and Clinical Cancer Research, Frontiers in Oncology, Cancer Management and Research, Oncology Letters), and serves on many grant review panels (e.g. CDMRP, NYUAD, CSF, FWF). He also actively servers as a Bentham Ambassador and a member of several leadership & committees for international conferences.
Prof. Rossana Berardi, MD is Professor in Medical Oncology at Università Politecnica Marche (UNIVPM). She is Director of Medical Oncology Department, Director of the Postgraduate School of Oncology, Head of “Genetic Cancer” Laboratory and coordinator of the Breast Unit at UNIVPM–Ospedali Riuniti,Ancona,Italy. She is member of the European Hyponatremia network and of the European Society for Medical Oncology (ESMO) “Core Curriculum” WG. She has been awarded many grants (ASCO and ESMO merit awards, Italian Oscar Prize for best researcher, international “Power to make the difference” award). She has authored >200 manuscripts in indexed journals, she has been speaker at national and international meetings and in advisory boards on NETs,chest tumors,breast cancer,SIADH and on clinical and translational research. Prof. Berardi was a Research Fellow at University College London Hospitals. She has been selected as expert evaluator in several boards (i.e. European Community, Italian University Ministry). She active in promoting innovative projects for patients and caregivers.
Prof. (Dr.) Renata Dobrila is presently working as Head of Department for Radiotherapy and Oncology, Clinical Hospital Centre Rijeka and Professor of Internal Medicine on School of Medicine, University of Rijeka, Croatia. Master of science acchieved in 1987, Specialist of Internal medicine 1995, PhD 1999, Assistant Professor 2003, Medical Oncologist subspecialization 2005 and Professor 2009 During education and careear development participated in numerous international courses, including Zagreb, Boston, Miami, New York, Chicago. In the same time participated as international speaker on Postgraduate courses related to oncology, chemotherapy and pain management in Moscow, Hong Kong, Rovingno and as International Invited speaker in Vienna, Chicago, Moscow, Bucharest, Philadelphia, Athenes, Sarajevo, Bangkok. All together more than 50 participation that covered various aspects of research and management of oncologic patients. Results of work presented in over 50 international publications and 10 books. Involved in several projects sponsored by Croatian Ministry of Health. Member of numerous International and National organizations, including IASGO, MASCC, ASCO, ESMO, EACR and vicepresident of Croatian Medical Oncology Society.
Dr.Vishnu K Tandon (Ph.D. – Medicinal chemistry) from Central Drug Research Institute, Lucknow is Professor of Chemistry and Former Head of the Chemistry Department and Dean, Faculty of Science, University of Lucknow, India. He did his Postdoctoral studies from Robert Robinson Laboratories, University of Liverpool, U.K. and University of Groningen, The Netherlands. He has published more than 100 papers (including patents and reviews) in reputed journals and serving as an associate editorial board member of journal of repute.
Dr. Sheeja K has been a project scientist since July 2015 in Regional Cancer Centre, Thiruvananthapuram, Kerala, India. Previously she served as a Scientist in SIBB R&D Cochin, where shewas responsible for teaching Post Graduate and Ph.D students as well as involved in various researches. Her research expertise mainly on tumor induced inflammation and metastasis. She is also interested in Chemopreventive role of phytochemical in different cancers. Currently she is involved in research onNLRP3 inflammasome and metastasis in human cancers. She has publications in Peer reviewed International journals and presented papers in many National and International conferences/Seminars/workshops.